Cargando…
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hyperglycemia, hypertension, and dyslipidemias. The syndrome affects 25% of adults worldwide. The definition of MS has evolved over the last 80 years, with various classification systems and criteria, wh...
Autores principales: | Rojas, Milagros, Chávez-Castillo, Mervin, Pirela, Daniela, Parra, Heliana, Nava, Manuel, Chacín, Maricarmen, Angarita, Lissé, Añez, Roberto, Salazar, Juan, Ortiz, Rina, Durán Agüero, Samuel, Gravini-Donado, Marbel, Bermúdez, Valmore, Díaz-Camargo, Edgar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308252/ https://www.ncbi.nlm.nih.gov/pubmed/34208833 http://dx.doi.org/10.3390/nu13072254 |
Ejemplares similares
-
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022) -
Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
por: Bermúdez, Valmore, et al.
Publicado: (2021) -
Microbiota and Diabetes Mellitus: Role of Lipid Mediators
por: Salazar, Juan, et al.
Publicado: (2020) -
Advanced Glycation End Products: New Clinical and Molecular Perspectives
por: Salazar, Juan, et al.
Publicado: (2021) -
The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
por: Martínez, María Sofía, et al.
Publicado: (2021)